Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
SSR Mining
SSRM
$5.32B
| $22.3M | ﹤0.01% |
1,017,299
+610,386
| +150% | +$13.6M |
|
2202
CALL
Tenet Healthcare
THC
$20.5B
| $22.3M | ﹤0.01% |
112,200
-67,800
| -38% | -$13.7M |
|
2203
NewAmsterdam Pharma
NAMS
$3.25B
| $22.3M | ﹤0.01% |
635,247
+428,786
| +208% | +$15.6M |
|
2204
CALL
Macy's
M
$6.53B
| $22.3M | ﹤0.01% |
1,009,800
-301,900
| -23% | -$6.18M |
|
2205
Global X Silver Miners ETF NEW
SIL
$3.98B
| $22.2M | ﹤0.01% |
266,155
+162,318
| +156% | +$12M |
|
2206
PUT
Canadian Imperial Bank of Commerce
CM
$108B
| $22.2M | ﹤0.01% |
245,300
-10,700
| -4% | -$918K |
|
2207
PUT
Tyson Foods
TSN
$20.4B
| $22.2M | ﹤0.01% |
378,900
-37,000
| -9% | -$2.03M |
|
2208
CALL
Allstate
ALL
$68B
| $22.2M | ﹤0.01% |
106,700
+46,400
| +77% | +$9.5M |
|
2209
Lionsgate Studios
LION
$3.95B
| $22.2M | ﹤0.01% |
2,430,110
+1,625,328
| +202% | +$11.6M |
|
2210
PUT
Skyworks Solutions
SWKS
$9.37B
| $22.2M | ﹤0.01% |
349,800
+72,600
| +26% | +$5.07M |
|
2211
PUT
Sprouts Farmers Market
SFM
$8.13B
| $22.2M | ﹤0.01% |
278,300
+64,200
| +30% | +$5.76M |
|
2212
Ford
F
$58.5B
| $22.2M | ﹤0.01% |
1,689,902
-3,451,432
| -67% | -$44.5M |
|
2213
PUT
O'Reilly Automotive
ORLY
$72.9B
| $22.2M | ﹤0.01% |
242,900
-17,500
| -7% | -$1.71M |
|
2214
CALL
LyondellBasell Industries
LYB
$20B
| $22.2M | ﹤0.01% |
511,600
+341,600
| +201% | +$15.5M |
|
2215
Baxter International
BAX
$13.5B
| $22.1M | ﹤0.01% |
1,156,466
-735,907
| -39% | -$14.7M |
|
2216
Hancock Whitney
HWC
$6.2B
| $22.1M | ﹤0.01% |
346,529
+267,649
| +339% | +$16.3M |
|
|
GTM
2217
ZoomInfo Technologies
GTM
$973M
| $22M | ﹤0.01% |
2,165,427
+2,083,991
| +2,559% | +$21.5M |
|
2218
PUT
MasTec
MTZ
$21.1B
| $22M | ﹤0.01% |
101,300
+54,500
| +116% | +$11.4M |
|
|
ORKA
2219
Oruka Therapeutics
ORKA
$5.82B
| $22M | ﹤0.01% |
726,118
+409,232
| +129% | +$11.4M |
|
2220
Latham Group
SWIM
$629M
| $22M | ﹤0.01% |
3,463,172
-1,156,942
| -25% | -$8.09M |
|
2221
CALL
Global X Copper Miners ETF NEW
COPX
$7.29B
| $22M | ﹤0.01% |
306,300
+86,100
| +39% | +$5.52M |
|
2222
Enliven Therapeutics
ELVN
$3.92B
| $21.9M | ﹤0.01% |
1,424,344
+263,841
| +23% | +$5.26M |
|
2223
Onto Innovation
ONTO
$12.9B
| $21.9M | ﹤0.01% |
138,766
-252,516
| -65% | -$35.9M |
|
2224
Nurix Therapeutics
NRIX
$2.41B
| $21.9M | ﹤0.01% |
1,152,930
+587,625
| +104% | +$8.44M |
|
2225
ProShares UltraPro Short QQQ
SQQQ
$2.04B
| $21.9M | ﹤0.01% |
319,015
+252,062
| +376% | +$17.8M |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,363 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.